banner
Vancomycin-loaded PLGA nanoparticles surface-modified with galactose (PLGA(Van)@Galactose)
Inquiry

Cat. No.: X26-06-ZQ4728

Vancomycin-loaded PLGA nanoparticles surface-modified with galactose (PLGA(Van)@Galactose)

Synonym: PLGA(Van)@Galactose; Vancomycin-loaded PLGA nanoparticles surface-modified with galactose; PLGA-Van-Gal carbohydrate targeted matrix spheres; Vancomycin loaded PLGA galactose; PLGA(Van)@Galactose receptor targeted caps

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
Hydrolytic PLGA nanoparticles containing vancomycin, modified with terminal galactose targets for ASGPR binding.
Source
Custom synthesis
Functional Group
Vancomycin; PLGA; Galactose
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Applications
Baseline hepatic accumulation comparison assays, parenchymal liver tissue localization, and extended release tracking.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.